It was revealed that a high ADRA2C expression level was associated with a favorable OS in GBM-LGG (HR= 0.53, p<0.001) and uveal melanoma (UVM) (HR= 0.34, p=0.017) (Figures 3B and 3C), while a high ADRA2C expression level was correlated with a poor OS in adrenocortical carcinoma (ACC) (HR=2.35, p=0.035) (Figure 3A). Here, ADRA2C is linked to glioblastoma.